Lipid levels in Pegnant women. Other obstetric conditions, not elsewhere classified
Conditions
Interventions
Intervention 1: Group interventions: fish oil capsules (containing 120 mg of DHA and 180 mg, 1000 mg EPA) ,Every day 1 number. Intervention 2: Control group: placebo (same shape, size and weight with
Treatment - Drugs
Placebo
Group interventions: fish oil capsules (containing 120 mg of DHA and 180 mg, 1000 mg EPA) ,Every day 1 number
Control group: placebo (same shape, size and weight with other capsules ,Every day 1 number
Sponsors
Endocrine Research Center, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: willingness to participate in the study, aged 18-35 years, first to fifth pregnancy, pregnant women with 16-20weeks of gestation, single pregnancy; BMI less than 30, healthy pregnant women with no previous underlying medical condition, including heart disease, kidney, gastrointestinal, respiratory, autoimmune, diabetes, impaired glucose tolerance testing in the current pregnancy, thyroid, epilepsy, hypertension underlying psychiatric disorders, hyperlipidemia and not to use any drugs because of the above conditions .Exclusion criteria:, bleeding, placenta previa, placenta detachment in current pregnancy, infertility and premature labor history, the existence of any history of allergy to fish or fish oil or other products or allergic to gelatin, the unfortunate incident that had occurred 6 months prior to the study, smoking or drugs, bleeding disorders or taking anticoagulants, participating in another study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipid Profile. Timepoint: begiining of study,fifth care of pregnancy. Method of measurement: blood analysis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Aslani
Tabriz University of Medical Sciences
Outcome results
None listed